Novel mutations in mevalonate kinase cause disseminated superficial actinic porokeratosis. (1st August 2019)

• Record Type: Journal Article
• Authors: Zhu, T.; Tian, D.; Zhang, L.; Xu, X.; Xia, K.; Hu, Z.; Xiong, Z.; Tan, J.
• Is Part Of: British journal of dermatology. Volume 181:Number 2(2019)
• Page Start: 304
• Page End: 313
• Publication Date: 2019-08-01
• Subjects: Dermatology -- Periodicals; Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/bjd.17596
• Languages: English
• ISSNs: 0007-0963

Abstract

Summary: Background: Disseminated superficial actinic porokeratosis (DSAP) is a rare autosomal dominant disease. In our previous research, we found that a linkage region of DSAP in a large family is located at 12q23·2‐q24·1. Subsequently, the mevalonate kinase gene ( MVK ) was shown to be pathogenic in DSAP. Objectives: To elucidate the mechanism by which MVK mutations lead to keratinocyte apoptosis and DSAP, and to report a new missense mutation, c.566 C>T (p.A189V), in MVK in a Chinese DSAP pedigree. Methods: The half‐life of wild‐type (WT) MVK protein and mutants was assessed using cycloheximide treatment of cells. Dimerization of MVK was analysed by coimmunoprecipitation and glutathione S transferase pull‐down assay. MVK kinase activity, production of cell cholesterol, mitochondrial complex activity and apoptosis were detected, using the corresponding commercial kits, in cells overexpressing MVK WT and mutants. Results: Mechanically, we demonstrated that both the pathogenic p.A189V mutant and a sporadic mutation p.H312R (c.935A>G), which we reported previously, have rapid degradation, decreased kinase activity and reduced production of cell cholesterol. Also, we found the p.H312R mutation confers on the MVK protein an inability to dimerize. Further, we demonstrated that the mutants are impaired in mitochondrial function and lead to increased apoptosis. Conclusions: Our results provide an important basis for elucidating the mechanism by which MVK missense mutations contribute to DSAP.